Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB29TN
|
|||
| Drug Name |
MER4101
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza [ICD-11: 1E30-1E32; ICD-10: J10, J11; ICD-9: 487, 488] | Phase 1 | [1] | |
| Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1 | [2] | ||
| Company |
Mercia Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02500680) The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (MER4101). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02500680) The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.